Cost Effectiveness of Meningococcal Serogroup B Vaccination in College-Aged Young Adults.

ABSTRACT: INTRODUCTION:Neisseria meningitidis serogroup B is the most common form of meningococcal infection in young adults in the U.S. Vaccines have recently become available, but it is not clear that the benefits outweigh the costs. The purpose of this study was to assess cost effectiveness and determine potentially favorable conditions for universal vaccination. METHODS:Costs and benefits of universal vaccination at college entry versus no universal vaccination with an outbreak response were estimated in 2018 in the context of a mid-sized U.S.-based 4-year college from both a health sector and a societal perspective. Probability, cost, and utility data were obtained from the published literature. Costs (2015 U.S.$) and benefits were discounted at 3%. One-way and multivariable probabilistic sensi

SUBMITTER: Leeds IL 

PROVIDER: S-EPMC6340776 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature